Promoting Antiretroviral Therapy Among Serodiscordant Couples to Reduce HIV Transmission
NCT ID: NCT01764282
Last Updated: 2017-08-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
11096 participants
INTERVENTIONAL
2012-01-01
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
We-INtervention Among Chinese HIV-serodiscordant Male Couples
NCT06639932
Couple-based Intervention on Quality of Life in HIV Male Serodiscordant Couples
NCT06497751
Testing and Linkage to HIV Care in China
NCT02084316
A Cluster-Randomized Intervention Trial to Improve Quality of Life for HIV-Infected Individuals in Anhui, China
NCT00479141
HIV Clinic-Based Intervention to Improve ART Adherence and Prevent HIV Transmission
NCT02044484
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
comprehensive intervention components
comprehensive intervention components
ART promotion, Couple testing and consulting promotion, and Condom use promotion
Usual
According the National HIV Antiretroviral treatment Guideline, provide treatment referrals for those treatment-eligible HIV-positive patients.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
comprehensive intervention components
ART promotion, Couple testing and consulting promotion, and Condom use promotion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Older than 18 years and younger than 60 years; without regard to CD4 count;
* Open cohort(any newly diagnosed serodiscordant couples who are eligible for treatment will be included during the study period).
Exclusion Criteria
* Younger than 18 years old.
18 Years
59 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Center for AIDS/STD Control and Prevention, China CDC
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zuyou Wu, MD, PHD
Role: PRINCIPAL_INVESTIGATOR
National Center for AIDS/STD Control and Prevention, China CDC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center for Disease Control and Prevention,Guangxi Zhuang Autonomous Region
Nanning, Guilin, Laibin, Qinzhou, Guangxi, China
Center for Disease Control and Prevention, Henan Province
Zhumadian, Henan, China
Center for Disease Control and Prevention, Sichuan Province
Liangshan, Sichuan, China
Center for Disease Control and Prevention, Xinjiang Uygur Autonomous Region
Urumchi, Ili, Xinjiang, China
Center for Disease Control and Prevention, Yunnan Province
Kunming, Dehong, Wenshan, Honghe, Yunnan, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Zhang F, Dou Z, Ma Y, Zhang Y, Zhao Y, Zhao D, Zhou S, Bulterys M, Zhu H, Chen RY. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. Lancet Infect Dis. 2011 Jul;11(7):516-24. doi: 10.1016/S1473-3099(11)70097-4.
Cohen MS, Gay CL. Treatment to prevent transmission of HIV-1. Clin Infect Dis. 2010 May 15;50 Suppl 3(0 3):S85-95. doi: 10.1086/651478.
Stephenson R, Barker J, Cramer R, Hall MA, Karita E, Chomba E, Vwalika C, Allen S. The demographic profile of sero-discordant couples enrolled in clinical research in Rwanda and Zambia. AIDS Care. 2008 Mar;20(3):395-405. doi: 10.1080/09540120701593497.
He N, Duan S, Ding Y, Rou K, McGoogan JM, Jia M, Yang Y, Wang J, Montaner JS, Wu Z; China National HIV Prevention Study Group. Antiretroviral therapy reduces HIV transmission in discordant couples in rural Yunnan, China. PLoS One. 2013 Nov 13;8(11):e77981. doi: 10.1371/journal.pone.0077981. eCollection 2013.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012ZX10001007-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.